Table 2.
Relationship between fibroblast MCT4 and prognostic biomarkers.
| Papillary Thyroid Carcinoma (n=46) | |||
|---|---|---|---|
| Low stromal MCT4 | High stromal MCT4 | p-value | |
| No adenopathy | 100% (10/10) | 37% (17/36) | 0.001 |
| No ETE | 100% (10/10) | 61% (22/36) | 0.020 |
| Low ATA risk | 100% (10/10) | 58% (21/36) | 0.0009 |
| Low AMES risk | 100% (10/10) | 39% (14/36) | 0.020 |